The Clalit Research Institute in Israel has been designated the WHO Collaborating Centre on Noncommunicable Diseases (NCDs) Research, Prevention and Control, under the WHO European Region’s Division of Noncommunicable Diseases and Life-Course.
As part of our mandate as a WHO Collaborating Centre, we undertake activities to contribute to policy development, prioritization and planning pertaining to the implementation of the Global Action Plan for the prevention and control of NCDs 2013-2020.
Additionally, as a WHO Collaborating Centre, we provide technical support in the follow-up of the September 2013 Tallinn meeting on the use of new data sources in NCD surveillance, and follow-up of the December 2014 Vilnius meeting on integrated NCD surveillance.
Terms of Reference
- To contribute to policy development, prioritization and planning pertaining to the implementation of the Global Action Plan for the prevention and control of NCDs 2013-2020, the Action Plan for implementation of the European Strategy for the Prevention and Control of Noncommunicable Diseases (NCDs) and the Ashgabat Declaration on the prevention and control of NCDs in the context of Health 2020.
- To contribute to building the evidence base supporting the strategy and action plan for healthy aging in Europe, 2012–2020.
Featured MeetingsSee full list >
Joint WHO/Europe and ECDC Webinar “COVID-19 vaccine uptake and effectiveness.”
29 March 2021
A joint webinar took place between the WHO Regional Office for Europe and the European Centre for Disease Prevention and Control on the topic of COVID-19 vaccine uptake and effectiveness.
Joint WHO/Europe and ECDC Webinar “Monitoring uptake and effectiveness of COVID-19 vaccine in the WHO European Region”
8 March 2021
The aim of this meeting was to provide an updated picture on the reporting and dissemination of information on COVID-19 vaccine uptake and deployment in the European Region, as well as share specific country experiences in conducting vaccine effectiveness studies.